Invention Grant
US09562092B2 Methods of inhibiting complement C4 activation with anti-complement C1s antibodies
有权
用抗补体C1s抗体抑制补体C4活化的方法
- Patent Title: Methods of inhibiting complement C4 activation with anti-complement C1s antibodies
- Patent Title (中): 用抗补体C1s抗体抑制补体C4活化的方法
-
Application No.: US14932174Application Date: 2015-11-04
-
Publication No.: US09562092B2Publication Date: 2017-02-07
- Inventor: Peter Van Vlasselaer , Graham Parry , Nancy E. Stagliano , Sandip Panicker
- Applicant: True North Therapeutics, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: True North Therapeutics, Inc.
- Current Assignee: True North Therapeutics, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Bozicevic Field & Francis, LLP
- Agent Paula A. Borden
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/18 ; C07K16/40 ; A01N1/02 ; A61K49/00 ; A61K49/16 ; A61K51/10 ; G01N33/68 ; A61K39/00
Abstract:
The present disclosure provides antibodies that bind complement C1s protein; and nucleic acid molecules that encode such antibodies. The present disclosure also provides compositions comprising such antibodies, and methods to produce and use such antibodies, nucleic acid molecules, and compositions.
Public/Granted literature
- US20160053002A1 ANTI-COMPLEMENT C1S ANTIBODIES AND USES THEREOF Public/Granted day:2016-02-25
Information query
